TransMedics (NASDAQ:TMDX) expects Q1 revenues of $7.4M – 7.5M, up ~59% (midpoint) from a year ago and above consensus of $6.9M.
Management is withdrawing 2020 guidance due to COVID-19 disruptions.
https://seekingalpha.com/news/3560308-transmedics-sees-59-jump-in-q1-top-line-withdraws-guidance-due-to-covidminus-19
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.